Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Parkinson Disease l: Introduction

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

Alterations in Muscle Tone lll

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

REM Sleep Behavior Disorder

REM Sleep Behavior Disorder

REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

An efficient optimization method to improve the measuring accuracy of oxygen saturation by using triangular wave optical signal.

The Review of scientific instruments·2017

Same author

The Research Progress of Mesenchymal Stem Cells in the Treatment of Traumatic Brain Injury.

Turkish neurosurgery·2017

Same author

Antidiabetic Effect of Tibetan Medicine Tang-Kang-Fu-San on High-Fat Diet and Streptozotocin-Induced Type 2 Diabetic Rats.

Evidence-based complementary and alternative medicine : eCAM·2017

Same author

[Standardized investigation on medicinal nature of ethnomedicine].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2017

Same author

Development of fine solid-crystal suspension with enhanced solubility, stability, and aerosolization performance for dry powder inhalation.

International journal of pharmaceutics·2017

Same author

Synchronous acquisition of multi-channel signals by single-channel ADC based on square wave modulation.

The Review of scientific instruments·2017

Same journal

The Protective Effects of Small-Molecule Compound 0242 Against LPS-Induced Neuroinflammation and in P301S Tau Transgenic Mice.

Neurochemical research·2026

Same journal

Vorinostat Rescues Cognitive Deficits in a Neuroinflammatory Mouse Model: A Study of Sex Differences and the Underlying TLR4/NF-κB Mechanism.

Neurochemical research·2026

Same journal

MST4 Regulates Microglia Neuroinflammation via Targeting PKM2 Nuclear Translocation in Epilepsy: An In Vivo and In Vitro Study.

Neurochemical research·2026

Same journal

Correction to: Dual Antioxidant DH-217 Mitigated Cerebral Ischemia-Reperfusion Injury by Targeting IKKβ/Nrf2/HO-1 Signal Axis.

Neurochemical research·2026

Same journal

Microglia-Dependent BDNF Signaling in the Dentate Gyrus Underlies the Antidepressant Effects of Gardiquimod, a Toll-Like Receptor 7 Agonist, in Chronically Stressed Mice.

Neurochemical research·2026

Same journal

Cryptotanshinone Targets Ferroptosis in Glioma via the EGFR/ROS Signaling Pathway.

Neurochemical research·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 25, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

Contralateral retinal dopamine decrease and melatonin increase in progression of hemiparkinsonium rat.

Tao Meng¹, Zhi-Hong Zheng, Ting-Ting Liu

¹Department of Biochemistry and Molecular Biology, Fujian Medical University, Fuzhou 350004, China.

Neurochemical Research

|January 19, 2012

Summary

This summary is machine-generated.

Parkinson's disease (PD) models show decreased dopamine in the contralateral eye and increased melatonin in both eyes. These changes in neuromodulators correlate with disease progression.

More Related Videos

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

The 6-hydroxydopamine Rat Model of Parkinson's Disease

The 6-hydroxydopamine Rat Model of Parkinson's Disease

Published on: October 27, 2021

Related Experiment Videos

Last Updated: May 25, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

The 6-hydroxydopamine Rat Model of Parkinson's Disease

The 6-hydroxydopamine Rat Model of Parkinson's Disease

Published on: October 27, 2021

Area of Science:

Neuroscience
Ophthalmology
Pharmacology

Background:

Dopamine (DA) and melatonin (MLT) are key retinal neuromodulators.
Retinal DA deficiency and altered MLT levels are implicated in Parkinson's disease (PD).
Previous research has not explored ipsilateral and contralateral retinal DA and MLT in PD models.

Purpose of the Study:

To investigate retinal dopamine and melatonin changes in a 6-hydroxydopamine (6-OHDA) induced hemiparkinsonian rat model.
To examine the relationship between these neuromodulators and PD progression.

Main Methods:

Established a PD rat model via unilateral 6-OHDA injection.
Measured retinal DA, its metabolites (DOPAC, HVA), and MLT concentrations using HPLC.
Collected eye tissue at two daily time points (10:00 and 22:00).

Main Results:

Significantly decreased DA levels in the eye contralateral to the 6-OHDA lesion.
Increased DOPAC/DA and HVA/DA ratios in the lesioned eye.
Distinctly increased MLT concentrations in both eyes post-lesion.
Neuromodulator changes correlated with observed rotation behavior.

Conclusions:

Unilateral 6-OHDA injection primarily affects DA-containing neurons in the contralateral eye.
Elevated retinal MLT levels are associated with PD progression in this model.
Retinal DA and MLT serve as potential biomarkers for PD.